Source: Annual Congress 2005 - Miscellaneous diffuse parenchymal lung disease
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Sobiecka, R. Langfort, I. Bestry, P. Radwan-Roehrenschef, J. Kus (Warsaw, Poland). Pulmonary alveolar proteinosis (PAP) - clinical features and response to treatment by bronchofiberoscopic lobar lavage. Eur Respir J 2005; 26: Suppl. 49, 3501

Member's Comments

No comment yet.

Related content which might interest you: Mini-whole lung lavage to treat pulmonary alveolar proteinosis (PAP) Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020 Pulmonary alveolar proteinosis: failure of treatment by bronchoscopic lobar lavages and GM-CSF treatment in a child Source: Eur Respir J 2003; 22: Suppl. 45, 309s Year: 2003 Idiopathic pulmonary alveolar proteinosis: GM CSF therapy and whole lung lavage a case report Source: Eur Respir J 2003; 22: Suppl. 45, 44s Year: 2003 Whole lung lavage (WLL) for patients with pulmonary alveolar proteinosis Source: Eur Respir J 2004; 24: Suppl. 48, 670s Year: 2004 Outpatient lobar lavage: a novel approach to managing pulmonary alveolar proteinosis Source: Virtual Congress 2020 – Interventional pulmonology: diagnostic and therapeutic approaches Year: 2020 Whole lung lavage (WLL) in pulmonary alveolar proteinosis (PAP): long-term lung function follow-up Source: Eur Respir J 2001; 18: Suppl. 33, 220s Year: 2001 A gene network to predict the clinical response to whole lung lavage (WLL), in pulmonary alveolar proteinosis (PAP). Source: International Congress 2017 – Novel and old entities Year: 2017 Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis Source: Eur Respir J 2004; 23: 526-531 Year: 2004 BAL cytology in pulmonary alveolar proteinosis: a review of 7 cases Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008 Pulmonary alveolar proteinosis Source: Respipedia Article Year: 2017 The benefits of whole lung lavage in pulmonary alveolar proteinosis Source: Eur Respir J 2004; 23: 503-505 Year: 2004 Determinants of protein concentration in whole lung lavage of patients with pulmonary alveolar proteinosis Source: Annual Congress 2009 - From genetics to clinics in diffuse parenchymal lung diseases Year: 2009 Whole lung lavage efficacy in pulmonary alveolar proteinosis (PAP) is influenced by the infusion volume? Source: International Congress 2015 – IIPs: orphan Year: 2015 Is it possible to predict the outcome of the whole lung lavage (WLL) in pulmonary alveolar proteinosis (PAP)? Source: International Congress 2015 – IIPs: orphan Year: 2015 Pulmonary alveolar proteinosis: from classification to therapy Source: Breathe, 16 (2) 200018; 10.1183/20734735.0018-2020 Year: 2020 Pulmonary alveolar proteinosis and long-term outcome after bronchopulmonary lavage Source: International Congress 2017 – Paediatric bronchology Year: 2017 Whole lung lavage therapy (WLL) of pulmonary alveolar proteinosis (PAP): A global survey of current practices and procedures Source: International Congress 2016 – Orphan diseases I Year: 2016 Pulmonary alveolar proteinosis therapy success with combined lavage procedures: a case report Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009 Call for an international survey on therapeutic lavage for pulmonary alveolar proteinosis Source: Eur Respir J 2012; 39: 1049 Year: 2012 Lung cysts in pulmonary alveolar proteinosis. Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018